Astera Labs (NASDAQ:ALAB) Stock Rating Upgraded by Wall Street Zen

07 Nov 2026, 05:07 by Doug Wharley · The Cerbat Gem

Astera Labs (NASDAQ:ALAB – Get Free Report) was upgraded by investment analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a report released on Saturday, Wall Street Zen reports.

ALAB has been the subject of several other reports. Susquehanna dropped their price objective on shares of Astera Labs from $310.00 to $258.00 and set a “neutral” rating for the company in a research note on Wednesday. BMO Capital Markets assumed coverage on shares of Astera Labs in a research note on Thursday. They set an “outperform” rating and a $375.00 target price for the company. Zacks Research cut Astera Labs from a “strong-buy” rating to a “hold” rating in a report on Monday, October 5th. Needham & Company LLC lowered their price objective on shares of Astera Labs from $425.00 to $300.00 and set a “buy” rating for the company in a research report on Wednesday. Finally, Roth Capital reaffirmed a “buy” rating and set a $450.00 price objective on shares of Astera Labs in a report on Wednesday, August 5th. Thirteen investment analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $320.85.

Get Our Latest Analysis on ALAB

Astera Labs Trading Up 6.3%

Shares of NASDAQ:ALAB opened at $190.71 on Friday. The stock has a market capitalization of $33.09 billion, a PE ratio of 148.17 and a beta of 3.85. Astera Labs has a 1 year low of $97.89 and a 1 year high of $499.48. The firm has a fifty day moving average price of $300.46 and a 200 day moving average price of $255.80.

Astera Labs (NASDAQ:ALAB – Get Free Report) last released its earnings results on Tuesday, November 3rd. The company reported $1.32 earnings per share for the quarter, beating the consensus estimate of $1.19 by $0.13. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%. The firm had revenue of $584.90 million for the quarter, compared to analyst estimates of $550.78 million. During the same quarter in the prior year, the firm posted $0.49 earnings per share. The company’s quarterly revenue was up 153.6% on a year-over-year basis. On average, sell-side analysts forecast that Astera Labs will post 2.71 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Astera Labs news, CEO Jitendra Mohan sold 90,630 shares of the stock in a transaction on Monday, August 17th. The stock was sold at an average price of $340.35, for a total transaction of $30,845,920.50. Following the completion of the transaction, the chief executive officer directly owned 1,266,665 shares of the company’s stock, valued at approximately $431,109,432.75. This represents a 6.68% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, General Counsel Philip Mazzara sold 6,801 shares of the firm’s stock in a transaction dated Monday, August 17th. The stock was sold at an average price of $340.50, for a total transaction of $2,315,740.50. Following the completion of the sale, the general counsel directly owned 96,542 shares of the company’s stock, valued at approximately $32,872,551. This represents a 6.58% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold a total of 396,059 shares of company stock valued at $123,408,470 over the last quarter. 10.40% of the stock is owned by insiders.

Hedge Funds Weigh In On Astera Labs

Several large investors have recently made changes to their positions in ALAB. BlackRock Inc. acquired a new position in Astera Labs in the second quarter valued at $6,609,581,000. Bank of America Corp DE acquired a new stake in Astera Labs in the 2nd quarter valued at $1,061,791,000. Atreides Management LP grew its holdings in shares of Astera Labs by 108.9% in the 1st quarter. Atreides Management LP now owns 3,365,787 shares of the company’s stock valued at $368,890,000 after buying an additional 1,754,593 shares during the period. Amundi grew its stake in Astera Labs by 77.9% in the 1st quarter. Amundi now owns 1,880,830 shares of the company’s stock valued at $206,139,000 after buying an additional 823,477 shares during the last quarter. Finally, Deutsche Bank AG bought a new position in Astera Labs in the 2nd quarter valued at approximately $325,602,000. 60.47% of the stock is currently owned by institutional investors and hedge funds.

Trending Headlines about Astera Labs

Here are the key news stories impacting Astera Labs this week:

Positive Sentiment: Astera Labs reported Q3 revenue of $584.9 million, up 154% year over year, and its Scorpio switch business was highlighted as a major growth driver. One Seeking Alpha contributor upgraded the stock, citing Scorpio’s momentum and gross margins that may stabilize near 72%. Astera Labs: So Much To Like In Q3 (Upgrade)
Positive Sentiment: BMO Capital initiated coverage with an Outperform rating and a $375 price target; Northland Securities also upgraded the stock to Outperform. These calls provide a counterpoint to recent selling and valuation worries. BMO Capital Initiates Coverage on Astera Labs With Outperform Rating Astera Labs Upgraded to Outperform at Northland Securities
Neutral Sentiment: Analyst views remain divided, with one recent opinion arguing that the selloff may already reflect a potential growth slowdown in 2027. Astera Labs: Sell-Off Already Priced In 2027 Stall
Negative Sentiment: A reported analyst downgrade triggered renewed pressure, while coverage also points to ALAB’s rich valuation after its Q3 results. Those concerns may amplify selling when technology stocks are broadly weak. Shares Gap Down After Analyst Downgrade Stock Drops After Q3 Results Spotlight Rich Valuation
Negative Sentiment: Astera Labs was caught in a wider technology-sector selloff, adding market-wide pressure beyond company-specific news. Astera Labs Falls Amid Tech Selloff

About Astera Labs

(Get Free Report)

Astera Labs, Inc is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help move data among processors, accelerators, memory and other components in high-performance computing systems.

The company’s portfolio includes Aries PCIe and CXL retimers, Taurus Ethernet smart cable modules, Scorpio fabric switches and Leo CXL memory connectivity controllers. Astera Labs also offers software tools to help customers configure and monitor its connectivity products.